Enveric Biosciences

Company snapshot

Enveric Biosciences is a pharma organization headquartered in CAMBRIDGE, MA, USA. It trades on NYSE under ticker ENVB. NovaPharmaNews links 0 clinical program(s), 0 drug profile(s), and 22 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources.

• 22 US patent(s) indexed to this assignee profile.

Public regulatory, clinical, patent, and corporate records for Enveric Biosciences. Not investment advice.

Recent activity

Latest pipeline, patent, and corporate events for Enveric Biosciences.

1. Sep 30, 2025 Patent grant

   Fused heterocyclic mescaline derivatives

2. Aug 5, 2025 Patent grant

   Aminated psilocybin derivatives and methods of using

3. Jul 15, 2025 Patent grant

   Substituted n-propylamine fused heterocyclic mescaline derivatives

4. Jun 24, 2025 Patent grant

   N-heterocycle substituted tryptamine derivatives and methods of using

5. Jan 14, 2025 Patent grant

   C1-substituted isopropylamine fused heterocyclic mescaline derivatives

View all clinical trial activity →

• What is Enveric Biosciences?

  Enveric Biosciences is a pharma organization headquartered in CAMBRIDGE, MA, USA. It trades on NYSE under ticker ENVB. NovaPharmaNews links 0 clinical program(s), 0 drug profile(s), and 22 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources

• Is Enveric Biosciences publicly traded?

  Yes. Enveric Biosciences is listed with ticker ENVB on NYSE per SEC EDGAR records linked on this profile.

• What drugs does Enveric Biosciences develop or market?

  No drug profiles are currently linked to Enveric Biosciences. Pipeline programs may still list investigational assets.

• What are the latest developments for Enveric Biosciences?

  In the last 12 months our linked public records show 0 trial program update(s) and 4 US patent grant(s) tied to this profile.

• What therapeutic areas does Enveric Biosciences focus on?

  No specific therapeutic focus areas are currently identified for Enveric Biosciences in our database.